(Q40857039)

24 September 2017

Stage T3 prostate cancer: a nonrandomized comparison between definitive irradiation and induction hormonal manipulation plus prostatectomy (English)

1 reference

24 September 2017

Corn BW

1

1 reference

24 September 2017

Valicenti RK

2

1 reference

24 September 2017

Mulholland SG

3

1 reference

24 September 2017

Hyslop T

4

1 reference

24 September 2017

Gomella L

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

24 September 2017

1 reference

24 September 2017

51

1 reference

24 September 2017

5

1 reference

24 September 2017

782-787

1 reference

Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Induction androgen deprivation plus prostatectomy for stage T3 disease: failure to achieve prostate-specific antigen-based freedom from disease status in a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Eight years experience with neutron radiotherapy in the treatment of stages C and D prostate cancer: updated results of the RTOG 7704 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Do the current subclassifications of stage T3 adenocarcinoma of the prostate have clinical relevance?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83-07

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

The role of neoadjuvant hormonal manipulation in localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Potential for radiotherapy alone in prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

Prostate-specific antigen following prostate radiotherapy: how low can you go?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900022-3

7 January 2021

10.1016/S0090-4295(98)00022-3

Identifiers

DOI

1 reference

24 September 2017

1 reference